Tekla Healthcare Opportunities Fund
Name
As of 11/01/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
2.0%
1 yr return
10.1%
3 Yr Avg Return
-4.7%
5 Yr Avg Return
1.8%
Net Assets
$928 M
Holdings in Top 10
46.2%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.66%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 57.85%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Closed-end mutual fund
Name
As of 11/01/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
XTHQX - Profile
Distributions
- YTD Total Return 2.0%
- 3 Yr Annualized Total Return -4.7%
- 5 Yr Annualized Total Return 1.8%
- Capital Gain Distribution Frequency N/A
- Net Income Ratio 0.69%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Monthly
Fund Details
-
Legal NameTekla Healthcare Opportunities Fund
-
Fund Family NameTekla Capital Management LLC
-
Inception DateAug 06, 2014
-
Shares Outstanding41356058
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerDaniel Omstead
Fund Description
XTHQX - Performance
Return Ranking - Trailing
Period | XTHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.0% | -26.9% | 24.4% | 89.31% |
1 Yr | 10.1% | -7.8% | 49.2% | 96.23% |
3 Yr | -4.7%* | -32.5% | 9.5% | 82.24% |
5 Yr | 1.8%* | -4.9% | 13.7% | 93.15% |
10 Yr | 4.0%* | 0.1% | 13.3% | 91.89% |
* Annualized
Return Ranking - Calendar
Period | XTHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -4.5% | -12.6% | 19.0% | 90.57% |
2022 | -11.8% | -53.9% | 3.2% | 35.53% |
2021 | 15.8% | -39.6% | 24.2% | 5.92% |
2020 | 3.9% | -13.6% | 178.2% | 86.58% |
2019 | 13.8% | 3.8% | 63.8% | 87.97% |
Total Return Ranking - Trailing
Period | XTHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 2.0% | -26.9% | 24.4% | 89.31% |
1 Yr | 10.1% | -7.8% | 49.2% | 96.23% |
3 Yr | -4.7%* | -32.5% | 9.5% | 82.24% |
5 Yr | 1.8%* | -4.9% | 13.7% | 93.15% |
10 Yr | 4.0%* | 0.1% | 13.3% | 91.89% |
* Annualized
Total Return Ranking - Calendar
Period | XTHQX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -4.5% | -12.6% | 19.0% | 93.08% |
2022 | -11.8% | -53.9% | 3.7% | 57.24% |
2021 | 15.8% | -33.9% | 26.0% | 21.05% |
2020 | 3.9% | -0.7% | 180.6% | 97.99% |
2019 | 17.9% | 4.6% | 63.8% | 95.49% |
NAV & Total Return History
XTHQX - Holdings
Concentration Analysis
XTHQX | Category Low | Category High | XTHQX % Rank | |
---|---|---|---|---|
Net Assets | 928 M | 6.87 M | 47.2 B | 50.94% |
Number of Holdings | 185 | 26 | 430 | 6.29% |
Net Assets in Top 10 | 456 M | 2.12 M | 22.1 B | 45.91% |
Weighting of Top 10 | 46.18% | 18.4% | 79.7% | 53.46% |
Top 10 Holdings
- UnitedHealth Group Inc 10.51%
- Johnson & Johnson 6.49%
- AbbVie Inc 5.16%
- Abbott Laboratories 4.11%
- Danaher Corp 3.80%
- Anthem Inc 3.75%
- Pfizer Inc 3.64%
- Thermo Fisher Scientific Inc 3.56%
- Eli Lilly and Co 3.52%
- Bristol-Myers Squibb Company 3.43%
Asset Allocation
Weighting | Return Low | Return High | XTHQX % Rank | |
---|---|---|---|---|
Stocks | 106.13% | 87.34% | 106.13% | 0.63% |
Bonds | 12.39% | 0.00% | 12.39% | 0.63% |
Cash | 3.26% | 0.00% | 33.01% | 33.96% |
Preferred Stocks | 1.21% | 0.00% | 7.86% | 20.13% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 88.96% |
Other | -22.99% | -22.99% | 23.24% | 100.00% |
Stock Sector Breakdown
Weighting | Return Low | Return High | XTHQX % Rank | |
---|---|---|---|---|
Healthcare | 94.11% | 59.26% | 100.00% | 98.05% |
Real Estate | 5.89% | 0.00% | 5.89% | 0.65% |
Utilities | 0.00% | 0.00% | 0.00% | 88.96% |
Technology | 0.00% | 0.00% | 22.69% | 90.91% |
Industrials | 0.00% | 0.00% | 7.02% | 90.91% |
Financial Services | 0.00% | 0.00% | 1.60% | 92.86% |
Energy | 0.00% | 0.00% | 0.00% | 88.96% |
Communication Services | 0.00% | 0.00% | 9.11% | 88.96% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 92.21% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 90.91% |
Basic Materials | 0.00% | 0.00% | 7.16% | 90.91% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | XTHQX % Rank | |
---|---|---|---|---|
US | 104.41% | 66.06% | 104.41% | 0.63% |
Non US | 1.72% | 0.00% | 28.87% | 52.83% |
Bond Sector Breakdown
Weighting | Return Low | Return High | XTHQX % Rank | |
---|---|---|---|---|
Corporate | 80.68% | 0.00% | 81.57% | 1.45% |
Cash & Equivalents | 19.32% | 0.00% | 100.00% | 5.66% |
Derivative | 0.00% | 0.00% | 23.24% | 89.94% |
Securitized | 0.00% | 0.00% | 0.00% | 88.41% |
Municipal | 0.00% | 0.00% | 0.00% | 88.41% |
Government | 0.00% | 0.00% | 29.44% | 89.13% |
Bond Geographic Breakdown
Weighting | Return Low | Return High | XTHQX % Rank | |
---|---|---|---|---|
US | 11.75% | 0.00% | 11.75% | 0.63% |
Non US | 0.64% | 0.00% | 3.33% | 1.26% |
XTHQX - Expenses
Operational Fees
XTHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.66% | 0.08% | 4.48% | 28.93% |
Management Fee | 1.00% | 0.03% | 1.25% | 92.45% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
XTHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 1.00% | N/A |
Trading Fees
XTHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
XTHQX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 57.85% | 0.00% | 238.00% | 62.96% |
XTHQX - Distributions
Dividend Yield Analysis
XTHQX | Category Low | Category High | XTHQX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.24% | 94.34% |
Dividend Distribution Analysis
XTHQX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Monthly | Annual | Quarterly | Annual |
Net Income Ratio Analysis
XTHQX | Category Low | Category High | XTHQX % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.69% | -2.54% | 1.85% | 11.18% |
Capital Gain Distribution Analysis
XTHQX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Semi-Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Jun 19, 2019 | $0.113 | OrdinaryDividend |
May 17, 2019 | $0.113 | OrdinaryDividend |
Apr 17, 2019 | $0.113 | OrdinaryDividend |
Mar 19, 2019 | $0.113 | OrdinaryDividend |
Feb 19, 2019 | $0.113 | OrdinaryDividend |
Jan 17, 2019 | $0.113 | OrdinaryDividend |
Dec 19, 2018 | $0.113 | OrdinaryDividend |
Nov 19, 2018 | $0.113 | OrdinaryDividend |
Sep 19, 2018 | $0.113 | OrdinaryDividend |
Aug 17, 2018 | $0.113 | OrdinaryDividend |
Jul 19, 2018 | $0.113 | OrdinaryDividend |
Jun 19, 2018 | $0.113 | OrdinaryDividend |
May 17, 2018 | $0.113 | OrdinaryDividend |
Apr 19, 2018 | $0.113 | OrdinaryDividend |
Mar 19, 2018 | $0.113 | OrdinaryDividend |
Feb 16, 2018 | $0.113 | OrdinaryDividend |
Jan 18, 2018 | $0.113 | OrdinaryDividend |
Dec 15, 2017 | $0.113 | OrdinaryDividend |
Nov 17, 2017 | $0.113 | OrdinaryDividend |
Oct 18, 2017 | $0.113 | OrdinaryDividend |
Sep 15, 2017 | $0.113 | OrdinaryDividend |
Aug 17, 2017 | $0.113 | OrdinaryDividend |
Jul 13, 2017 | $0.113 | OrdinaryDividend |
Jun 15, 2017 | $0.113 | OrdinaryDividend |
May 17, 2017 | $0.113 | OrdinaryDividend |
Apr 12, 2017 | $0.113 | OrdinaryDividend |
Mar 16, 2017 | $0.113 | OrdinaryDividend |
Feb 16, 2017 | $0.113 | OrdinaryDividend |
Jan 18, 2017 | $0.113 | OrdinaryDividend |
Dec 15, 2016 | $0.113 | OrdinaryDividend |
Nov 17, 2016 | $0.113 | OrdinaryDividend |
Oct 18, 2016 | $0.113 | OrdinaryDividend |
Sep 15, 2016 | $0.113 | OrdinaryDividend |
Aug 17, 2016 | $0.113 | OrdinaryDividend |
Jul 14, 2016 | $0.113 | OrdinaryDividend |
Jun 16, 2016 | $0.113 | OrdinaryDividend |
May 17, 2016 | $0.113 | OrdinaryDividend |
Apr 14, 2016 | $0.113 | OrdinaryDividend |
Mar 16, 2016 | $0.113 | OrdinaryDividend |
Feb 17, 2016 | $0.113 | OrdinaryDividend |
Jan 20, 2016 | $0.113 | OrdinaryDividend |
Dec 17, 2015 | $0.302 | ExtraDividend |
Dec 17, 2015 | $0.113 | OrdinaryDividend |
Nov 17, 2015 | $0.113 | OrdinaryDividend |
Oct 15, 2015 | $0.113 | OrdinaryDividend |
Sep 17, 2015 | $0.113 | OrdinaryDividend |
Aug 18, 2015 | $0.113 | OrdinaryDividend |
Jul 16, 2015 | $0.113 | OrdinaryDividend |
Jun 17, 2015 | $0.113 | OrdinaryDividend |
May 14, 2015 | $0.113 | OrdinaryDividend |
Apr 17, 2015 | $0.113 | OrdinaryDividend |
Mar 17, 2015 | $0.113 | OrdinaryDividend |
Feb 17, 2015 | $0.113 | OrdinaryDividend |
Jan 20, 2015 | $0.113 | OrdinaryDividend |
Dec 17, 2014 | $0.113 | OrdinaryDividend |
Nov 18, 2014 | $0.113 | OrdinaryDividend |
Oct 17, 2014 | $0.113 | OrdinaryDividend |
Sep 17, 2014 | $0.113 | OrdinaryDividend |
XTHQX - Fund Manager Analysis
Managers
Daniel Omstead
Start Date
Tenure
Tenure Rank
Jul 28, 2014
7.85
7.9%
Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.88 | 0.25 |